M/A-COM Technology Solutions Holdings, Inc. Reports Fourth Quarter and Fiscal Year 2013 Financial Results
Fourth Quarter Fiscal Year 2013 GAAP Results
-
Revenue was
$83.7 million , compared to$82.2 million in the prior quarter; - Gross margin was 44.6 percent, compared to 44.1 percent in the prior quarter;
- Operating margin was 8.8 percent, compared to 13.7 percent in the prior quarter;
-
Net income was
$4.2 million , or$0.09 per diluted share, compared to a net income of$9.4 million , or$0.20 per diluted share, in the prior quarter; and -
Cash and cash equivalents totaled
$110.4 million at quarter end.
Fourth Quarter Fiscal Year 2013 Non-GAAP Results
- Gross margin was 45.4 percent, compared to 45.0 percent in the prior quarter;
- Operating margin was 20.3 percent, compared to 19.8 percent in the prior quarter; and
-
Net income was
$12.0 million , or$0.25 per diluted share, compared to net income of$11.5 million , or$0.24 per diluted share, in the prior quarter.
Fiscal Year Results
Fiscal year 2013 revenue was
Business Outlook
For the first quarter ending
Conference Call
MACOM will host a conference call on
Additionally, this conference call will be broadcast live over the Internet and can be accessed by all interested parties in the Investors section of MACOM's website at http://www.macomtech.com. To listen to the live call, please go to the Investors section of MACOM's website and click on the conference call link at least fifteen minutes prior to the start of the conference call. For those unable to participate during the live broadcast, a replay will be available shortly after the call and will remain available for approximately 60 days.
About MACOM
MACOM (www.macomtech.com) is a leading supplier of high performance analog semiconductor solutions for use in radio frequency (RF), microwave, and millimeter wave applications. Recognized for its broad portfolio of products, MACOM serves diverse markets including CATV, wireless infrastructure, optical communications, aerospace and defense, automotive, industrial, medical, and mobile devices. MACOM builds on more than 60 years of experience designing and manufacturing innovative product solutions for customers worldwide.
Headquartered in
Special Note Regarding Forward-Looking Statements
This press release contains forward-looking statements based on MACOM management's beliefs and assumptions and on information currently available to our management. Forward-looking statements include, among others, information concerning our stated business outlook and future results of operations, our belief that growth in our catalog business will be the foundation for future organic and inorganic growth in the
Forward-looking statements contained in this press release reflect MACOM's current views about future events and are subject to risks, uncertainties, assumptions and changes in circumstances that may cause those events or our actual activities or results to differ materially from those expressed in any forward-looking statement. Although MACOM believes that the expectations reflected in the forward-looking statements are reasonable, it cannot and does not guarantee future events, results, actions, levels of activity, performance or achievements. Readers are cautioned not to place undue reliance on these forward-looking statements. A number of important factors could cause actual results to differ materially from those indicated by the forward-looking statements, including, among others, the potential for weakness or less than expected strength in our catalog business, continued weakness
in our Networks market, lower than expected demand in any or all of our four primary end markets or from any of our large OEM customers based on macro-economic weakness or otherwise, the potential for defense spending cuts, program delays, cancellations or sequestration, failures or delays by any customer in winning business or to make purchases from us in support of such business, lack of adoption or delayed adoption by customers and industries we serve of GaN or other solutions offered by us, failures or delays in porting and qualifying GaN process technology to our
Non-GAAP Financial Measures
In addition to GAAP reporting, MACOM provides investors with non-GAAP financial information, including gross margin, operating margin, net income, earnings per share and other data calculated on a non-GAAP basis. This non-GAAP information excludes amortization of acquisition-related intangibles, share-based and other non-cash compensation expense, restructuring charges, Optomai litigation settlement and costs, changes in the carrying values of liabilities measured at fair value, contingent consideration, other non-cash expenses, earn-out costs, exited leased facility costs and certain income tax items. Management does not believe that the excluded items are reflective of MACOM's underlying performance. The exclusion of these and other similar items from MACOM's non-GAAP presentation should not be interpreted as implying that these items are non-recurring, infrequent or unusual. MACOM believes this non-GAAP financial information provides additional insight into MACOM's on-going performance and has therefore chosen to provide this information to investors for a more consistent basis of comparison and to help them evaluate the results of MACOM's on-going operations and enable more meaningful period to period comparisons. These non-GAAP measures are provided in addition to, and not as a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. A reconciliation between GAAP and non-GAAP financial data is included in the supplemental financial data attached to this press release.
|
|||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS | |||||
(unaudited and in thousands, except per share data) | |||||
Three Months Ended | Fiscal Years | ||||
|
|
|
|
|
|
2013 | 2013 | 2012 | 2013 | 2012 | |
Revenue | $ 83,655 | $ 82,225 | $ 74,563 | $ 318,718 | $ 302,203 |
Cost of revenue | 46,375 | 45,932 | 43,029 | 179,019 | 167,301 |
Gross profit | 37,280 | 36,293 | 31,534 | 139,699 | 134,902 |
Operating expenses: | |||||
Research and development | 9,538 | 11,120 | 7,960 | 40,631 | 35,817 |
Selling, general and administrative | 13,090 | 12,980 | 11,730 | 49,642 | 44,754 |
Litigation settlement | 7,250 | — | — | 7,250 | — |
Contingent consideration | — | — | (2,945) | (577) | (3,922) |
Restructuring charges | — | 950 | 276 | 950 | 1,862 |
Total operating expenses | 29,878 | 25,050 | 17,021 | 97,896 | 78,511 |
Income from operations | 7,402 | 11,243 | 14,513 | 41,803 | 56,391 |
Other income (expense): | |||||
Accretion of common stock warrant liability | (2,277) | 1,060 | 5,966 | (4,312) | 3,175 |
Accretion of Class B conversion liability | — | — | — | — | (44,119) |
Interest expense | (201) | (190) | (150) | (817) | (695) |
Other income - related party | 79 | 123 | 94 | 372 | 185 |
Total other income (expense) | (2,399) | 993 | 5,910 | (4,757) | (41,454) |
Income before income taxes | 5,003 | 12,236 | 20,423 | 37,046 | 14,937 |
Income tax provision | 853 | 2,869 | 3,465 | 9,335 | 15,953 |
Net income (loss) | 4,150 | 9,367 | 16,958 | 27,711 | (1,016) |
Accretion of redeemable preferred stock and participating stock dividends | — | — | (49) | — | (2,616) |
Net income (loss) attributable to common stockholders | $ 4,150 | $ 9,367 | $ 16,909 | $ 27,711 | $ (3,632) |
Net income (loss) per share: | |||||
Basic | $ 0.09 | $ 0.20 | $ 0.37 | $ 0.60 | $ (0.15) |
Diluted | $ 0.09 | $ 0.20 | $ 0.36 | $ 0.59 | $ (0.15) |
Shares used to compute net income (loss) per share: | |||||
Basic | 46,301 | 46,066 | 45,235 | 45,916 | 24,758 |
Diluted | 47,585 | 47,221 | 46,913 | 47,302 | 24,758 |
|
||||||
RECONCILIATION OF GAAP TO NON-GAAP RESULTS | ||||||
(unaudited and in thousands, except per share data) | ||||||
Three Months Ended | ||||||
September 27, 2013 | June 28, 2013 | September 28, 2012 | ||||
Amount |
% Revenue |
Amount |
% Revenue |
Amount |
% Revenue |
|
Gross profit - GAAP | $ 37,280 | 44.6% | $ 36,293 | 44.1% | $ 31,534 | 42.3% |
Amortization expense | 479 | 0.6 | 473 | 0.6 | 841 | 1.1 |
Non-cash compensation expense | 216 | 0.3 | 243 | 0.3 | 335 | 0.4 |
Gross profit - non-GAAP | $ 37,975 | 45.4% | $ 37,009 | 45.0% | $ 32,710 | 43.9% |
Research and Development - GAAP |
|
11.4% |
|
13.5% |
|
10.7% |
Earn-out costs | 1,021 | 1.2 | (1,021) | (1.2) | — | — |
Non-cash compensation expense | (462) | (0.6) | (421) | (0.5) | (367) | (0.5) |
Research and Development - non-GAAP | $ 10,097 | 12.1% | $ 9,678 | 11.8% | $ 7,593 | 10.2% |
Selling, General and Administrative - GAAP | $ 13,090 | 15.6% | $ 12,980 | 15.8% | $ 11,730 | 15.7% |
Amortization expense | (315) | (0.4) | (315) | (0.4) | (545) | (0.7) |
Non-cash compensation expense | (1,052) | (1.3) | (756) | (0.9) | (871) | (1.2) |
Optomai litigation settlement and costs | (1,395) | (1.7) | (250) | (0.3) | (484) | (0.6) |
Earn-out costs | 569 | 0.7 | (569) | (0.7) | — | — |
Selling, General and Administrative - non-GAAP | $ 10,897 | 13.0% | $ 11,090 | 13.5% | $ 9,830 | 13.2% |
Total operating expenses - GAAP |
|
35.7% |
|
30.5% |
|
22.8% |
Amortization expense | (315) | (0.4) | (315) | (0.4) | (545) | (0.7) |
Non-cash compensation expense | (1,514) | (1.8) | (1,177) | (1.4) | (1,238) | (1.7) |
Optomai litigation settlement and costs | (8,645) | (10.3) | (250) | (0.3) | (484) | (0.6) |
Contingent consideration and earn-out costs | 1,590 | 1.9 | (1,590) | (1.9) | 2,945 | 3.9 |
Restructuring charges | — | — | (950) | (1.2) | (276) | (0.4) |
Total operating expenses - non-GAAP | $ 20,994 | 25.1% | $ 20,768 | 25.3% | $ 17,423 | 23.4% |
Income from operations - GAAP |
|
8.8% |
|
13.7% |
|
19.5% |
Amortization expense | 794 | 0.9 | 788 | 1.0 | 1,386 | 1.9 |
Non-cash compensation expense | 1,730 | 2.1 | 1,420 | 1.7 | 1,573 | 2.1 |
Optomai litigation settlement and costs | 8,645 | 10.3 | 250 | 0.3 | 484 | 0.6 |
Contingent consideration and earn-out costs | (1,590) | (1.9) | 1,590 | 1.9 | (2,945) | (3.9) |
Restructuring charges | — | — | 950 | 1.2 | 276 | 0.4 |
Income from operations - non-GAAP | $ 16,981 | 20.3% | $ 16,241 | 19.8% | $ 15,287 | 20.5% |
Net income - GAAP | $ 4,150 | 5.0% | $ 9,367 | 11.4% | $ 16,958 | 22.7% |
Amortization expense | 495 | 0.6 | 493 | 0.6 | 1,054 | 1.4 |
Non-cash compensation expense | 652 | 0.8 | 872 | 1.1 | 1,196 | 1.6 |
Optomai litigation settlement and costs | 5,394 | 6.4 | 157 | 0.2 | 368 | 0.5 |
Contingent consideration and earn-out costs | (992) | (1.2) | 995 | 1.2 | (2,239) | (3.0) |
Restructuring charges | — | — | 666 | 0.8 | 210 | 0.3 |
Accretion of common stock warrant liability | 2,277 | 2.7 | (1,060) | (1.3) | (5,966) | (8.0) |
Non-cash interest expense | 46 | 0.1 | 46 | 0.1 | 54 | 0.1 |
Non-recurring tax items | — | — | — | — | (1,202) | (1.6) |
Net income - non-GAAP | $ 12,022 | 14.4% | $ 11,536 | 14.0% | $ 10,433 | 14.0% |
Amount | Per Share | Amount | Per Share | Amount | Per Share | |
Net income - GAAP: | ||||||
Net income | $ 4,150 |
|
$ 9,367 |
|
$ 16,958 |
|
Accretion of redeemable preferred stock and participating stock dividends | — | — | — | — | (49) | — |
Net income attributable to common stockholders | $ 4,150 |
|
$ 9,367 |
|
$ 16,909 |
|
Net income - non-GAAP | $ 12,022 |
|
$ 11,536 |
|
$ 10,433 |
|
Diluted shares - GAAP | 47,585 | 47,221 | 46,913 | |||
Incremental stock options, warrants, restricted stock and units | 946 | 1,003 | 513 | |||
Diluted shares - non-GAAP | 48,531 | 48,224 | 47,426 |
|
||||
RECONCILIATION OF GAAP TO NON-GAAP RESULTS | ||||
(unaudited and in thousands, except per share data) | ||||
Fiscal Years | ||||
September 27, 2013 | September 28, 2012 | |||
Amount |
% Revenue |
Amount |
% Revenue |
|
Gross profit - GAAP | $ 139,699 | 43.8% | $ 134,902 | 44.6% |
Amortization expense | 1,900 | 0.6 | 1,988 | 0.7 |
Non-cash compensation expense | 1,039 | 0.3 | 715 | 0.2 |
Gross profit - non-GAAP | $ 142,638 | 44.8% | $ 137,605 | 45.5% |
Research and Development - GAAP | $ 40,631 | 12.7% | $ 35,817 | 11.9% |
Non-cash compensation expense | (1,688) | (0.5) | (979) | (0.3) |
Research and Development - non-GAAP | $ 38,943 | 12.2% | $ 34,838 | 11.5% |
Selling, General and Administrative - GAAP | $ 49,642 | 15.6% | $ 44,754 | 14.8% |
Amortization expense | (1,260) | (0.4) | (1,317) | (0.4) |
Non-cash compensation expense | (3,369) | (1.1) | (2,068) | (0.7) |
Optomai litigation settlement and costs | (1,996) | (0.6) | (484) | (0.2) |
Exited leased facility costs | (1,267) | (0.4) | — | — |
Selling, General and Administrative - non-GAAP | $ 41,750 | 13.1% | $ 40,885 | 13.5% |
Total operating expenses - GAAP |
|
30.7% |
|
26.0% |
Amortization expense | (1,260) | (0.4) | (1,317) | (0.4) |
Non-cash compensation expense | (5,057) | (1.6) | (3,047) | (1.0) |
Optomai litigation settlement and costs | (9,246) | (2.9) | (484) | (0.2) |
Exited leased facility costs | (1,267) | (0.4) | — | — |
Contingent consideration and earn-out costs | 577 | 0.2 | 3,922 | 1.3 |
Restructuring charges | (950) | (0.3) | (1,862) | (0.6) |
Total operating expenses - non-GAAP | $ 80,693 | 25.3% | $ 75,723 | 25.1% |
Income from operations - GAAP |
|
13.1% |
|
18.7% |
Amortization expense | 3,160 | 1.0 | 3,305 | 1.1 |
Non-cash compensation expense | 6,096 | 1.9 | 3,762 | 1.2 |
Optomai litigation settlement and costs | 9,246 | 2.9 | 484 | 0.2 |
Exited leased facility costs | 1,267 | 0.4 | — | — |
Contingent consideration and earn-out costs | (577) | (0.2) | (3,922) | (1.3) |
Restructuring charges | 950 | 0.3 | 1,862 | 0.6 |
Income from operations - non-GAAP | $ 61,945 | 19.4% | $ 61,882 | 20.5% |
Net income (loss)- GAAP |
|
8.7% |
|
(0.3)% |
Amortization expense | 1,977 | 0.6 | 2,361 | 0.8 |
Non-cash compensation expense | 3,806 | 1.2 | 2,688 | 0.9 |
Optomai litigation settlement and costs | 5,771 | 1.8 | 346 | 0.1 |
Exited leased facility costs | 793 | 0.2 | — | — |
Contingent consideration and earn-out costs | (358) | (0.1) | (2,802) | (0.9) |
Restructuring charges | 666 | 0.2 | 1,330 | 0.4 |
Accretion of common stock warrant liability | 4,312 | 1.4 | (3,175) | (1.1) |
Accretion of Class B conversion liability | — | — | 44,119 | 14.6 |
Non-cash interest expense | 201 | 0.1 | 194 | 0.1 |
Non-recurring tax items | — | — | (1,961) | (0.6) |
Net income - non-GAAP | $ 44,879 | 14.1% | $ 42,084 | 13.9% |
Amount | Per Share | Amount | Per Share | |
Net income (loss) - GAAP: | ||||
Net income (loss) | $ 27,711 | $ 0.59 | $ (1,016) | $ (0.04) |
Accretion of redeemable preferred stock and participating stock dividends | — | — | (2,616) | (0.11) |
Net income (loss) attributable to common stockholders | $ 27,711 | $ 0.59 | $ (3,632) | $ (0.15) |
Net income - non-GAAP | $ 44,879 | $ 0.93 | $ 42,084 | $ 0.94 |
Diluted shares - GAAP | 47,302 | 24,758 | ||
Convertible preferred stock | — | 17,803 | ||
Incremental stock options, warrants, restricted stock and units | 815 | 2,351 | ||
Diluted shares - non-GAAP | 48,117 | 44,912 |
|
||
CONDENSED CONSOLIDATED BALANCE SHEETS | ||
(unaudited and in thousands) | ||
|
September 28, | |
2013 | 2012 | |
ASSETS | ||
Current assets: | ||
Cash and cash equivalents | $ 110,446 | $ 84,528 |
Accounts receivable, net | 62,961 | 54,184 |
Inventories | 53,995 | 57,459 |
Deferred income taxes and other current assets | 17,272 | 16,863 |
Total current assets | 244,674 | 213,034 |
Property and equipment, net | 31,563 | 30,209 |
Goodwill and intangible assets, net | 21,889 | 22,766 |
Other assets | 5,905 | 2,064 |
TOTAL ASSETS | $ 304,031 | $ 268,073 |
LIABILITIES AND STOCKHOLDERS' EQUITY | ||
Current liabilities: | ||
Accounts payable, accrued liabilities and other | $ 40,897 | $ 47,735 |
Deferred revenue | 9,030 | 7,992 |
Total current liabilities | 49,927 | 55,727 |
Common stock warrant liability | 11,873 | 7,561 |
Deferred income taxes and other long-term liabilities | 5,007 | 5,327 |
Total liabilities | 66,807 | 68,615 |
Commitments and contingencies | ||
Stockholders' equity | 237,224 | 199,458 |
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $ 304,031 | $ 268,073 |
|
||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | ||
(unaudited and in thousands) | ||
Fiscal Years | ||
|
|
|
2013 | 2012 | |
CASH FLOWS FROM OPERATING ACTIVITIES: | ||
Net income (loss) | $ 27,711 | $ (1,016) |
Non-cash adjustments | 18,770 | 55,425 |
Payment of contingent consideration | (5,328) | — |
Change in operating assets and liabilities | (4,352) | (19,055) |
Net cash from operating activities | 36,801 | 35,354 |
CASH FLOWS FROM INVESTING ACTIVITIES: | ||
Purchases of property and equipment | (11,769) | (15,679) |
Purchases of intangible assets | (897) | — |
Net cash used in investing activities | (12,666) | (15,679) |
CASH FLOWS FROM FINANCING ACTIVITIES: | ||
Payment of contingent consideration | (675) | (15,000) |
Proceeds from initial public offering, net of underwriters' discount | — | 98,175 |
Payment of Class B preference | — | (60,000) |
Other financing activities, net | 2,458 | (3,990) |
Net cash from financing activities | 1,783 | 19,185 |
NET CHANGE IN CASH AND CASH EQUIVALENTS | 25,918 | 38,860 |
CASH AND CASH EQUIVALENTS — Beginning of period | 84,528 | 45,668 |
CASH AND CASH EQUIVALENTS — End of period | $ 110,446 | $ 84,528 |
Non-GAAP Reconciliation: | ||
Net cash from operating activities - GAAP | $ 36,801 | |
Litigation settlement | 7,250 | |
Contingent consideration payment | 5,328 | |
Net cash from operating activities - non-GAAP | $ 49,379 |
CONTACT: Company Contact:Source:M/A-COM Technology Solutions Holdings, Inc. Conrad Gagnon Senior Vice President and Chief Financial Officer P: 978-656-2550 E: Conrad.Gagnon@macomtech.com Investor Relations Contact:Shelton Group Leanne K. Sievers EVP, Investor Relations P: 949-224-3874 E: lsievers@sheltongroup.com
News Provided by Acquire Media